2nd Precision Medicine in Inflammatory Bowel Disease
March 19 to March 21, 2024
Hyatt Regency Boston, 1 Avenue de Lafayette, Boston, Massachusetts, 02111, United States
The rapidly evolving landscape from 2023 to 2024 has witnessed substantial industry strides. Advancements in artificial intelligence and robust biomarker development have revolutionized precision medicine, leading to numerous approvals, IND filings, and emerging companies. Reflecting these transformative changes, the Precision Medicine in Inflammatory Bowel Disease Summit returns from Tue, 19 Mar 2024 to Thu, 21 Mar 2024, uniting 100+ experts. This specialized gathering promises groundbreaking developments, accelerating drug optimization and ushering in a tailored approach to medicine, transcending the conventional one-size-fits-all paradigm.
In the ever-evolving landscape of European biopharma investment, the last year has seen significant milestones, with GSK investing €1 million in a biotech campus and AstraZeneca committing £1 billion to R&D and Corporate HQ. To thrive in this dynamic environment, the Lab Asset and Facility Management in Pharma Europe returns for its second year. This expert-led summit focuses on sharing insights to enhance operational excellence in laboratories across Europe. The event takes place from March 19 to 21, 2024, building on the success of 2023 and helping stakeholders navigate the challenges of the biopharma industry.
The assurance cookie is found and is being filtered in Google Analytics.
These cookies are used to collect information about how you interact
with our website and allow us to remember you. We use this
information in order to improve and customize your browsing
experience, and for analytics and metrics about our visitors both on
this website and other media. To find out more about the cookies we
use, see our